Notable Analyst Rating Changes 03/19: (JNPR) (TEVA) (EPD) Upgraded; (OWW) (HSBC) (IO) Downgraded
Goldman Sachs upgrades Teva Pharma (NYSE: TEVA) from Sell to Neutral and moved its price target from $40 up to $52. Click Here for more color.
Credit Suisse lifts Enterprise Products Partners (NYSE: EPD) from Neutral to Outperform.
Citi moves Transocean (NYSE: RIG) from Sell to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
Goldman Sachs chops Orbitz Worldwide Inc. (NYSE: OWW) from